leisure time -WSS

leisure time

author：Wikipedia 2025-10-01 21:40:59 - browse：41411

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： High breast density mammograms need follow

hotspot

explore

WSS

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Kaiser Permanente unions announce official strike date

Menendez indictment could see pharma lose a key ally

How the Dana

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

explore

leisure time

Wikipedia

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why do women spend more than men on medical expenses?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Inequities make cancer less preventable for women: report

Activists slam private health insurers over coverage restrictions

To bolster infectious disease surveillance, genomics powerhouses team up

How one medical school became remarkably diverse

How one patient went off dialysis — and others can too

The high cost of giving birth even with insurance

Medicare bonuses could stop drug shortages under Senate plan

hotspot

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Listen: Who gets the credit for GLP

FDA endorses new sterilization method for medical devices

Pumping milk in bathrooms at health conferences is common

A pediatrician calls for Congress to pass the child tax credit deal

Senator probes 340B programs at Cleveland Clinic, Bon Secours

leisure time

hotspot

explore

Wikipedia